Dianthus Therapeutics (DNTH) Insider Trading & Ownership $37.44 +0.40 (+1.08%) As of 03:51 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Dianthus Therapeutics (NASDAQ:DNTH) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage8.15%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$700K Get DNTH Insider Trade Alerts Want to know when executives and insiders are buying or selling Dianthus Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DNTH Insider Buying and Selling by Quarter Dianthus Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/9/2025Ryan SavitzCFOSell20,000$35.00$700,000.00 (Data available from 1/1/2013 forward) DNTH Insider Trading Activity - Frequently Asked Questions Who is on Dianthus Therapeutics' Insider Roster? The list of insiders at Dianthus Therapeutics includes Fairmount Funds Management Llc, Ryan Savitz, and Simrat Randhawa. Learn more on insiders at DNTH. What percentage of Dianthus Therapeutics stock is owned by insiders? 8.15% of Dianthus Therapeutics stock is owned by insiders. Learn more on DNTH's insider holdings. Which Dianthus Therapeutics insiders have been buying company stock? The following insiders have purchased DNTH shares in the last 24 months: Fairmount Funds Management Llc ($1,126,752.10), and Simrat Randhawa ($26,400.00). How much insider buying is happening at Dianthus Therapeutics? Insiders have purchased a total of 86,670 DNTH shares in the last 24 months for a total of $1,153,152.10 bought. Which Dianthus Therapeutics insiders have been selling company stock? The following insider sold DNTH shares in the last 24 months: Ryan Savitz ($700,000.00). How much insider selling is happening at Dianthus Therapeutics? Insiders have sold a total of 20,000 Dianthus Therapeutics shares in the last 24 months for a total of $700,000.00 sold. Dianthus Therapeutics Key ExecutivesMr. Marino Garcia M.B.A. (Age 58)President, CEO, Secretary & Director Compensation: $496.02kMr. Ryan Savitz (Age 35)CFO and Chief Business Officer & Treasurer Compensation: $329.65k1 recent tradesMr. Simrat Randhawa M.B.A. (Age 54)M.D., Chief Medical Officer Compensation: $338.16kMr. Edward G. Carr (Age 55)Chief Accounting Officer Mr. Judson TaylorHead of Technical OperationsDr. Jeffrey Stavenhagen Ph.D.Chief Scientific OfficerMs. Jennifer Davis RuffVP and Head of Investor Relations & Corporate Affairs.Mr. Adam M. Veness Esq. (Age 38)Senior VP, General Counsel & Secretary Ms. Kristina MaximenkoChief People OfficerMs. Rashieda GluckHead of Clinical Development Operations More Insider Trading Tools from MarketBeat Related Companies Crinetics Pharmaceuticals Insider Trades Kymera Therapeutics Insider Trades Ultragenyx Pharmaceutical Insider Trades NewAmsterdam Pharma Insider Trades Viking Therapeutics Insider Trades Xenon Pharmaceuticals Insider Trades AMNEAL PHARMACEUTICALS Insider Trades Scholar Rock Insider Trades Immunovant Insider Trades Bausch Health Cos Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles $100 Million Buyback in Upwork Stock Follows a Strong Quarter Insiders Sell These High-Quality Stocks: Why Investors Shouldn’tCoreWeave and Madrigal's Insider Trades Flash Bullish SignalsPalantir Insider Selling: Risk Signal or Normal Activity?Loop Industries Insiders Buy Stock, Signal Confidence in Outlook This page (NASDAQ:DNTH) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredIf you own dollars, read this...Former Goldman Exec: "A Strange Day Is Coming to America" Dr. David Eifrig, who warned of inflation months ...Stansberry Research | SponsoredOpenAI’s new $300 billion dealOpenAI just signed a $300 billion cloud deal with Oracle to secure the computing power needed for its next Cha...Porter & Company | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored(Please Ignore if Already Rich)Discover how to get access to a weekly livestream with TWO Pro Traders for a full month… And learn their un...Monument Traders Alliance | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dianthus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dianthus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DNTH Stock Alerts